Yu-Feng Zhou Selected Research

cefquinome

1/2016	In Vivo Pharmacokinetics/Pharmacodynamics of Cefquinome in an Experimental Mouse Model of Staphylococcus Aureus Mastitis following Intramammary Infusion.
1/2016	Dose Assessment of Cefquinome by Pharmacokinetic/Pharmacodynamic Modeling in Mouse Model of Staphylococcus aureus Mastitis.
2/2015	In vitro dynamic pharmacokinetic/pharmacodynamic(PK/PD) modeling and PK/PD cutoff of cefquinome against Haemophilus parasuis.
1/2015	Pharmacokinetic/Pharmacodynamic Correlation of Cefquinome Against Experimental Catheter-Associated Biofilm Infection Due to Staphylococcus aureus.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yu-Feng Zhou Research Topics

Disease

10	Infections 01/2020 - 01/2015
5	Neoplasms (Cancer) 01/2021 - 01/2011
4	Chronic Obstructive Pulmonary Disease (COPD) 01/2022 - 12/2015
3	Respiratory Tract Infections (Respiratory Tract Infection) 01/2022 - 02/2015
3	Hepatocellular Carcinoma (Hepatoma) 11/2021 - 12/2018
2	Carcinogenesis 01/2022 - 11/2021
2	Pneumonia (Pneumonitis) 11/2020 - 01/2018
2	Bacteremia 01/2019 - 01/2018
2	Mastitis 01/2016 - 01/2016
1	Prostatic Neoplasms (Prostate Cancer) 01/2022
1	Fatty Liver 01/2022
1	Lung Neoplasms (Lung Cancer) 01/2021
1	Drug-Related Side Effects and Adverse Reactions 01/2021
1	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2021
1	Escherichia coli Infections 12/2020
1	Respiratory Tract Diseases (Respiratory Tract Disease) 03/2020
1	Neoplasm Metastasis (Metastasis) 12/2018
1	Liver Neoplasms (Liver Cancer) 12/2018
1	Lymphatic Metastasis 06/2018
1	Breast Neoplasms (Breast Cancer) 06/2018
1	Body Weight (Weight, Body) 01/2018
1	Clostridium Infections 12/2017
1	Obesity 11/2017
1	Thrombosis (Thrombus) 09/2017
1	Necrosis 09/2017
1	Hemorrhage 09/2017
1	Asthma (Bronchial Asthma) 01/2013
1	Uterine Cervical Neoplasms (Cancer of the Cervix) 12/2002
1	Endometrial Neoplasms (Endometrial Cancer) 12/2002
1	Uterine Neoplasms (Uterine Cancer) 12/2002

Drug/Important Bio-Agent (IBA)

4	cefquinomeIBA 01/2016 - 01/2015
3	Colistin (Coly-Mycin)FDA Link 12/2020 - 01/2017
3	antofloxacinIBA 11/2020 - 01/2017
2	Mechanistic Target of Rapamycin Complex 1IBA 01/2022 - 11/2021
2	Tigecycline (Tygacil)FDA Link 12/2020 - 01/2019
2	Amikacin (A.M.K)FDA LinkGeneric 01/2020 - 01/2017
2	Linezolid (Zyvox)FDA Link 01/2019 - 01/2018
2	Rifampin (Rifampicin)FDA LinkGeneric 01/2019 - 01/2018
2	Carbapenems (Carbapenem Antibiotics)IBA 01/2019 - 01/2017
2	Anti-Bacterial Agents (Antibiotics)IBA 01/2017 - 01/2015
2	Pharmaceutical PreparationsIBA 12/2015 - 01/2011
1	AndrogensIBA 01/2022
1	Androgen Receptors (Androgen Receptor)IBA 01/2022
1	danofloxacinIBA 01/2022
1	trametinibIBA 01/2021
1	Sirolimus (Rapamycin)FDA Link 01/2021
1	TOR Serine-Threonine KinasesIBA 01/2021
1	MacrolidesIBA 03/2020
1	gamithromycinIBA 03/2020
1	Immune Checkpoint InhibitorsIBA 01/2020
1	Nitrofurantoin (Macrodantin)FDA LinkGeneric 01/2020
1	carfilzomibIBA 12/2018
1	Sorafenib (BAY 43-9006)FDA Link 12/2018
1	Drug CombinationsIBA 12/2018
1	SuspensionsIBA 06/2018
1	CarbonIBA 06/2018
1	purineIBA 01/2018
1	valnemulinIBA 12/2017
1	MicroRNAs (MicroRNA)IBA 11/2017
1	Hematoxylin (Haematoxylon)IBA 09/2017
1	Eosine Yellowish-(YS) (Eosin)IBA 09/2017
1	Therapeutic UsesIBA 09/2017
1	tulathromycinIBA 01/2017
1	FluoroquinolonesIBA 01/2017
1	marbofloxacinIBA 12/2015
1	phenyl-2-aminoethyl sulfide (PAES)IBA 01/2015
1	AllergensIBA 01/2013

Therapy/Procedure

5	Therapeutics 11/2021 - 01/2018
2	Lymph Node Excision (Lymph Node Dissection) 06/2018 - 12/2002
1	Microbubbles 09/2017
1	Catheters 01/2015
1	Extracorporeal Shockwave Therapy 01/2011
1	Aftercare (After-Treatment) 01/2011
1	Hysterectomy 12/2002
1	Laparotomy 12/2002
1	Operative Surgical Procedures 12/2002